Anda belum login :: 22 Nov 2024 23:55 WIB
Home
|
Logon
Hidden
»
Administration
»
Collection Detail
Detail
Live Attenuated versus Inactivated Influenza Vaccine in Infants and Young Children
Oleh:
Belshe, Robert B
;
Edwards, Kathryn M
;
Vesikari, Timo
;
Black, Steven V
;
Walker, Robert E
;
Hultquist, Micki
;
Kemble, George
;
Connor, Edward M
Jenis:
Article from Journal - ilmiah internasional
Dalam koleksi:
The New England Journal of Medicine (keterangan: ada di Proquest) vol. 356 no. 07 (Feb. 2007)
,
page 685.
Ketersediaan
Perpustakaan FK
Nomor Panggil:
N08.K.2007.01
Non-tandon:
1 (dapat dipinjam: 0)
Tandon:
tidak ada
Lihat Detail Induk
Isi artikel
BACKGROUND Universal vaccination of children 6 to 59 months of age with trivalent inactivated influenza vaccine has recently been recommended by U.S. advisory bodies. To evaluate alternative vaccine approaches, we compared the safety and efficacy of intranasally administered live attenuated influenza vaccine with those o(jnactivated vaccine in infants and young children. METHODS Children 6 to 59 months of age, without a recent episode of wheezing illness or severe asthma, were randomly assigned in a 1:1 ratio to receive either cold-adapted trivalent live attenuated influenza vaccine (a refrigeration-stable formulation oflive attenuated intranasally administered influenza vaccine) or trivalent inactivated vaccine in a double-blind manner. Influenza-like illness was monitored with cultures throughout the 2004-2005 influenza season. RESULTS Safety data were available for 8352 children, and 7852 children completed the study according to the protocol. There were 54.9% fewer cases of cultured-confirmed influenza in the group that received live attenuated vaccine than in the group that received inactivated vaccine (153 vs. 338 cases, P
Opini Anda
Klik untuk menuliskan opini Anda tentang koleksi ini!
Kembali
Process time: 0.03125 second(s)